Lifemd, Inc. · NASDAQ:LFMD
Lifemd — Conversion Labs — Investor Presentation (December 2019)
17 slides from Lifemd's investor presentation, Dec 11, 2019
Slide 1: Advancing a new paradigm in health and wellness with technology
CONVERSIONLABS Advancing a new paradigm in health and wellness with technology Q@4 2019 Investor Presentation ‘as S
Slide 2: Safe Harbor
Safe Harbor Statements in this presentation that are not descriptions of historical facts are forward-looking statements relating to future events, and as such all forward-looking statements are made pursuant to the Securities Litigation Reform Act of 1995. Statements may contain certain forward-loo
Slide 3: Medical Questions
Medical Questions At Conversion Labs, we take a modern Getting started with your / online visit for hair loss approach to wellness and healthcare. | We apply our direct response marketing =a 1 expertise to healthcare to provide a Sig convenient, cost-effective and smarter way for consumers to access
Slide 4: An emerging leader in technology-driven healthcare and telemedicine
Conversion Labs - An emerging leader in technology-driven healthcare and telemedicine publicly traded on revenue run-rate ad impressions licensed for online Deloitte’s 2019 OTCQB and growing served in 2 years Rx (consults in 48) Fast 500 List CONVERSIONLABS
Slide 5: Strong revenue growth & financial performance
Strong revenue growth & financial performance | Highlights Consistent Revenue Growth 102% 93% $12,000,000 YOY Revenue Revenue CAGR Growth (Net) (2015-2019E) $10,000,000 $8,000,000 : & $6,000,000 @ $16m 150,000+ g Run-Rate & iS Growing Customers $4,000,000 8 fe} $2,000,000 Ss fal o Scalable business
Slide 6: Proven direct-response marketing ability
Proven direct-response marketing ability OTC Products $3,500,000.00 $1,200,000.00 $3,000,000.00 $1,000,000.00 $2,500,000.00 $800,000.00 $2,000,000.00 $600,000.00 $1,500,000.00 $400,000.00 $1,000,000.00 $200,000.00 $500,000.00 CONVERSIONLABS
Slide 7: Major consumer and healthcare trends are driving growth of telemedicine and e-wellness
Major consumer and healthcare trends are driving the growth of telemedicine and e-wellness Healthcare Trends = Costs of healthcare rising due to aging ‘ population and poor public policy = On average, it takes over two hours each . time a person seeks medical care* = Physician shortages responsible
Slide 8: Uniquely positioned for growth in direct response wellness and telemedicine
We are uniquely positioned for growth in direct response wellness and telemedicine Proven online, direct-response State-licensed physician marketing ability consults in 48 states CONVERSION
Slide 9: End-to-End telehealth customer acquisition model
End-to-End telehealth customer acquisition model 7. — Follow Up Rx refills, follow up consults, upsells, OTC product offerings 1 _ Acquisition Patient/customer views ad, visits our website, initiates OTC checkout or Rx screening 6. — Fulfillment Same day shipping of Rx and 06 incredible customer ser
Slide 10: Our Business Units
Our Business Units Over-The-Counter Prescription Strategic Investments $12m Q4 2019 $4m run-rate and growing launch run-rate and growing CONVERSIONL ABS
Slide 11: Over-the-counter brands
Over-the-counter brands SHAPIRO MD — HAIR GROWTH EXPERTS —— Developed by distinguished dermatologists Dr. Steven Shapiro, M.D., and Dr. Michael Borenstein, M.D. PhD 2 U.S. Patents; 15 years of product development and formulation work Includes naturally occurring DHT blocking system, FDA approved min
Slide 12: Rx brands
Rx brands rex Male oriented telemedicine brand Initial product focus on erectile dysfunction; to be expanded to sores, skin & acne, and men’s health Global market for erectile dysfunction drugs expected to reach USD $2.95 billion by 2023 Synergistic with existing OTC customer base @4 2019 Launch CON
Slide 13: Strategic Investments
Strategic Investments (= PDFSimpli {ef PDFSimpli Let's get started! Drag & Drop your PDF here CVLB acquired a 51% stake in PDF Simpli in June 2018. As of August 9, 2019, PDFSimpli was ranked in the top 20,000 websites globally and has more than 2M registered users. PDFSimpli has had over 6 terabytes
Slide 14: Peer Comparison
Peer Comparison F Market F 1 P A Ro (roman/rory) Private Men/Women TeleRx $500 Million ~$50M 173 Million+ Hims Private Men’s TeleRx $1 Billion ~$100 M 197 Million Thirty Madison (Keeps) Private Men’s Hair Loss Est. ~$50-100 M N/A 22.8 Million Lemonaid Health Private TeleRx/Counseling $60 M (18) Est.
Slide 15: Financial Highlights
Financial Highlights Share Structure (November 1, 201 Shares outstanding 53,504,045 Convertible Notes 14,120,000 Warrants* 11,326,225 Options* 20,945,000 Fully Diluted 92,710,725 Cash From Full Exercise of Options/Warrants $9,392,450.36 Stock Information Listing OTCQB Symbol CVLB 52-Week Stock Range
Slide 16: Management, board and advisors
Bo Justin Schreiber John R. Strawn, Jr. Anthony G. Bruzzese, M.D. Michael Borenstein, M.D. Joseph V. Ditrolio, M.D. Stefan Galluppi Bertrand Velge Happy Walters Justin Schreiber Stefan Galluppi Juan Manuel Pifieiro Dagnery Sean Fitzpatrick Nick Alvarez. of Directors Chairman Director Director Direct
Slide 17: Conversion Labs contact
CONVERSIONLABS Justin Schreiber Juan Manuel Pifieiro Dagnery President & CEO Cre justin@conversionlabs.com juan@conversionlabs.com NY: 800 Third Avenue, Suite 2800, New York, NY 10022 qe” CA: 5882 Bolsa Ave., Suite 230, Huntington Beach, CA 92648 PR: 53 Calle Las Palmeras, Suite 802, San Juan, PR OO
Conversion Labs — Investor Presentation (December 2019) on 6ix